Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Michael O'Riordan

July 21, 2016

News Daily News

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

L.A. McKeown

April 21, 2016

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

News Daily News

在心梗后进行抗血栓治疗的同时使用 NSAID 会增加出血、心血管事件

Yael L. Maxwell

February 25, 2015

News Daily News

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Yael L. Maxwell

February 25, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Caitlin E. Cox

June 03, 2013

Presentation

Vascular and Upper Gastrointestinal Effects of Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Presenter: CNT Collaboration

May 31, 2013

News Daily News

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Caitlin E. Cox

October 04, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

NSAIDs Plus Anticoagulants a Bad Combination

在心梗后进行抗血栓治疗的同时使用 NSAID 会增加出血、心血管事件

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Vascular and Upper Gastrointestinal Effects of Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content